A recent article by The Economist provides an overview of recent vaccine advances in the fight against malaria. Oxford scientists have developed a jab that shows 77% effectiveness and hope to apply for pre-qualification from the World Health Organization (WHO) in the fall. If it goes well, the Oxford version will be another great scientific breakthrough, complementing the RTS,S malaria vaccine that currently requires four doses and only reduces severe infections by 30%.